Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH STRIDES PHARMA SCIENCE PROCTER & GAMBLE HEALTH/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 34.4 -1,432.1 - View Chart
P/BV x 10.5 3.2 325.3% View Chart
Dividend Yield % 2.0 0.2 1,037.7%  

Financials

 PROCTER & GAMBLE HEALTH   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
STRIDES PHARMA SCIENCE
Mar-23
PROCTER & GAMBLE HEALTH/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs5,366392 1,368.1%   
Low Rs3,883263 1,473.9%   
Sales per share (Unadj.) Rs740.7408.5 181.3%  
Earnings per share (Unadj.) Rs138.2-25.6 -540.6%  
Cash flow per share (Unadj.) Rs155.21.4 11,342.3%  
Dividends per share (Unadj.) Rs95.001.50 6,333.3%  
Avg Dividend yield %2.10.5 449.0%  
Book value per share (Unadj.) Rs447.6242.8 184.3%  
Shares outstanding (eoy) m16.6090.30 18.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.20.8 777.8%   
Avg P/E ratio x33.5-12.8 -260.9%  
P/CF ratio (eoy) x29.8239.6 12.4%  
Price / Book Value ratio x10.31.4 765.2%  
Dividend payout %68.7-5.9 -1,171.4%   
Avg Mkt Cap Rs m76,76129,603 259.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0627,320 28.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29636,884 33.3%  
Other income Rs m1841,352 13.6%   
Total revenues Rs m12,48038,236 32.6%   
Gross profit Rs m3,247830 391.3%  
Depreciation Rs m2812,433 11.6%   
Interest Rs m82,611 0.3%   
Profit before tax Rs m3,142-2,862 -109.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847-553 -153.2%   
Profit after tax Rs m2,295-2,309 -99.4%  
Gross profit margin %26.42.2 1,173.7%  
Effective tax rate %27.019.3 139.6%   
Net profit margin %18.7-6.3 -298.1%  
BALANCE SHEET DATA
Current assets Rs m11,71331,353 37.4%   
Current liabilities Rs m6,79129,902 22.7%   
Net working cap to sales %40.03.9 1,017.9%  
Current ratio x1.71.0 164.5%  
Inventory Days Days26371 369.4%  
Debtors Days Days343129 267.1%  
Net fixed assets Rs m10,61731,300 33.9%   
Share capital Rs m166903 18.4%   
"Free" reserves Rs m7,26521,025 34.6%   
Net worth Rs m7,43121,928 33.9%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m22,33063,734 35.0%  
Interest coverage x409.1-0.1 -426,293.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.6 95.2%   
Return on assets %10.30.5 2,172.9%  
Return on equity %30.9-10.5 -293.3%  
Return on capital %42.4-0.8 -5,637.6%  
Exports to sales %046.7 0.0%   
Imports to sales %13.10-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs m1,605NA-   
Fx inflow Rs m1,46518,113 8.1%   
Fx outflow Rs m1,605672 239.1%   
Net fx Rs m-14017,442 -0.8%   
CASH FLOW
From Operations Rs m2,360444 531.4%  
From Investments Rs m-2153,025 -7.1%  
From Financial Activity Rs m-985-2,139 46.0%  
Net Cashflow Rs m1,1601,328 87.4%  

Share Holding

Indian Promoters % 0.0 27.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 38.9 52.1%  
FIIs % 7.6 19.5 39.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 72.6 66.4%  
Shareholders   56,730 91,182 62.2%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs STRIDES PHARMA SCIENCE Share Price Performance

Period Procter & Gamble Health STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day -0.69% -0.45% 1.18%
1-Month -7.59% -1.26% -0.75%
1-Year -3.15% 172.46% 61.82%
3-Year CAGR -9.16% -3.87% 18.16%
5-Year CAGR 5.72% 10.62% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.